The Global CBD Gummies Market is Expected to Grow

CBD gummies could offer investors a multi-billion-dollar opportunity. In fact, the CBD gummies market could reach approx. $6.94 billion by 2025, according to Grand View Research. That’s great news for

Pure Extracts Technologies Corp

. (CSE: PULL) (OTC: PRXTF)(XFRA: A2QJAJ),

Canopy Growth Corporation

(NASDAQ:CGC)(TSX:WEED),

Tilray Inc.

(NASDAQ:TLRY),

Charlotte’s Web Holdings Inc.

(TSX:CWEB)(OTC:CWBHF), and

cbdMD Inc.

(NYSE:YCBD). Better, according to Hemp Industry Daily, “Considering that the market could see favorable U.S. Food and Drug Administration guidance or legislation from Congress approving CBD in ingestible products next year, Nielsen expects that by 2025, the market for hemp-derived CBD products will generate $6.9 billion – a threefold increase over five years.”


Look at Pure Extracts Technologies Corp. for example



Pure Extracts Technologies Corp


. just announced that it has purchased over 500 kg (1,100 lbs.) of high potency dry cannabis flower in preparation for the launch next month of retail sales of its Pure Pulls vapes and Pure Chews edible gummies. Demand for these types of products is strong in the 4 provinces (British Columbia, Alberta, Saskatchewan and Ontario) that the Company is targeting for its retail launch and revenue estimates associated with this shipment are just over $1,000,000.

Pure Extracts CEO, Ben Nikolaevsky, remarked, “Q2 is going to be very exciting for us as we commence retail sales of vapes and gummies through our distribution partner. Our exceptionally pure products are in high demand and we have a range in potencies and flavours that consumers will certainly enjoy.”


Other related developments from around the markets include:


Canopy Growth Corporation,

a world-leading diversified cannabis, hemp, and vaporization device company, has entered the

high-potential U.S. CBD beverage category

with the launch of Quatreau, a premium ready-to-drink CBD-infused sparkling water. The stateside launch follows the successful 2020 rollout of Canopy Growth’s CBD-infused beverages in Canada, where Quatreau is now the top-selling ready-to-drink CBD beverage. Quatreau sparkling water contains 20 mg of premium, U.S. grown hemp-based CBD and one of four refreshing flavors. With an MSRP of $3.99 per 12-ounce can, Quatreau is a functional zero-sugar drink that delivers a natural, low calorie beverage alternative at an accessible price point.


Tilray Inc.

(NASDAQ:TLRY), a global pioneer in cannabis research, cultivation, production and distribution,

reported financial results

for the full fiscal year and fourth quarter ended December 31, 2020. All financial information in this press release is reported in U.S. dollars, unless otherwise indicated. Brendan Kennedy, Tilray’s Chief Executive Officer, stated, “Over the course of 2020, and despite COVID-19 related challenges, we transformed and strengthened Tilray, delivered solid full year results, significantly reduced net loss, and achieved our stated goal of delivering break even or positive Adjusted EBITDA in Q4 2020. We did so by generating meaningful revenue growth across our core businesses, particularly international medical and Canadian adult-use in Q4, and reducing costs by $57 million on an annualized basis compared to Q4 of 2019. As a result, we now operate with a more focused, efficient and competitive cost structure. We also strengthened our balance sheet and positioned Tilray for growth and success in the future in combination with Aphria. These results required hard work and dedication and I sincerely appreciate everything the Tilray team has done to transform our business during 2020. We now look forward to the beginning of the next chapter in our corporate journey.”


Charlotte’s Web Holdings Inc.

(TSX:CWEB)(OTC:CWBHF), the market leader in full-spectrum hemp CBD extract products, announces that it has entered into an

Option Purchase Agreement with Stanley Brothers USA

Holdings, Inc., a privately-held Delaware company, and the shareholders of Stanley Brothers USA. Stanley Brothers USA is a cannabis wellness incubator currently operating in three states (Colorado, California, Florida) with expansion plans underway in eight additional states. The Option has a five-year term (extendable for an additional two years) and provides Charlotte’s Web the optionality to acquire Stanley Brothers USA on the earlier of three years from the effective date of the Option and federal legalization of cannabis in the United States, or such earlier time as Stanley Brothers USA and Charlotte’s Web may agree potentially including when otherwise permitted by the policies of the stock exchange on which the Company’s securities are listed for trading. The common shares of Charlotte’s Web continue to trade on the TSX in Canada and OTCQX in the US.


cbdMD Inc.

(NYSE:YCBD), one of the leading, and most highly trusted and recognized cannabidiol (CBD) brands, announced that it has formed

cbdMD Therapeutics LLC

, a newly formed wholly-owned subsidiary of the Company for the purposes of isolating and quantifying the Company’s ongoing investments in science related to its existing and future products, including research and development activities for therapeutic applications.

Legal Disclaimer / Except for the historical information presented herein, matters discussed in this article contains forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Winning Media is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. For making specific investment decisions, readers should seek their own advice. Winning Media is only compensated for its services in the form of cash-based compensation. Pursuant to an agreement Winning Media has been paid three thousand five hundred dollars for advertising and marketing services for Pure Extracts Technologies Corp. by Pure Extracts Technologies Corp. We own ZERO shares of Pure Extracts Technologies Corp. Please

click here

for full disclaimer.

Contact Information:

2818047972


[email protected]